首页 | 本学科首页   官方微博 | 高级检索  
     

喉癌组织中HPV16及其早期区基因E6、E7蛋白的表达及意义
引用本文:叶青[,] 赵舒薇[] 何金[] 强笔[] 英信江[]. 喉癌组织中HPV16及其早期区基因E6、E7蛋白的表达及意义[J]. 第二军医大学学报, 2007, 28(1): 0064-0067
作者姓名:叶青[  ] 赵舒薇[] 何金[] 强笔[] 英信江[]
作者单位:1. 第二军医大学长征医院耳鼻咽喉科,上海,200003;长征医院附属闸北分院耳鼻咽喉科,上海,200070
2. 第二军医大学长征医院耳鼻咽喉科,上海,200003
3. 长征医院病理科
基金项目:国家自然科学基金,上海市闸北区自然科学基金
摘    要:目的:观察喉癌组织中HPV16及其早期区基因E6、E7蛋白的表达,并初步分析其与喉癌组织临床分期、病理分级的相关性.方法:147例喉组织标本,其中喉鳞状细胞癌组织82例,非癌组织39例(声带息肉27例,距肿瘤>1.0 cm的癌周正常组织12例),癌前病变(声带白斑)26例.免疫组织化学检测各组标本中HPV16及其早期区基因E6、E7蛋白的表达.分析喉鳞癌组织中3种蛋白表达情况与临床分期、病理分级的相关性.结果:喉鳞癌组织中HPV16蛋白及E6、E7蛋白的阳性率明显高于癌前病变组织(P<0.05或0.01),后者高于非癌组织 (P<0.05或0.01).非癌组织中HPV16蛋白阳性率明显高于E6、E7蛋白的表达(P<0.05或0.01),而喉癌组织及癌前组织中三者间无显著差异.不同临床分期(Ⅰ~Ⅳ期)及不同病理分级(Ⅰ~Ⅲ级)喉癌组织中HPV16的阳性率间有显著差异(P<0.05);而不同临床分期及病理分级间HPV16 E6、E7蛋白表达率无显著差异.结论:HPV16感染后其早期区基因E6、E7的表达可能是诱发喉癌的因素之一,应用免疫学方法抑制E7蛋白的表达对于喉癌的治疗有积极的意义,但其预防和治疗作用不应过分夸大.

关 键 词:喉肿瘤  癌,鳞状细胞  HPV16蛋白  HPV16 E6蛋白  HPV16 E7蛋白
文章编号:0258-879X(2007)01-0064-04
收稿时间:2006-11-15
修稿时间:2006-12-25

Protein expression of HPV16 and its early gene E6, E7 in human laryngeal squamous cell carcinoma and its significance
YE Qing,ZHAO Shu-wei,HE Jin,QIANG Bi,YING Xin-jiang. Protein expression of HPV16 and its early gene E6, E7 in human laryngeal squamous cell carcinoma and its significance[J]. Former Academic Journal of Second Military Medical University, 2007, 28(1): 0064-0067
Authors:YE Qing  ZHAO Shu-wei  HE Jin  QIANG Bi  YING Xin-jiang
Affiliation:1. Department of Otolaryngology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China; 2. Department of Otolaryngology, Zhabei Branch of Changzheng Hospital, Shanghai 200070; 3. Department of Pathology, Changzheng Hospital
Abstract:Objective:To investigate the protein expression of HPV16 and its early gene E6, E7 in human laryngeal squamous cell carcinoma tissues, and to analyze their relationship with the clinical stage and pathological classification of laryngeal squamous cell carcinoma.Methods: The expression of HPV16, HPV16 E6, and HPV16 E7 protein was detected in 147 specimens of different laryngeal lesions immunohistochemically. The specimens included 82 laryngeal carcinoma, 39 non-carcinoma tissues (including 27 specimens of vocal cord polyp and 12 specimens of normal laryngeal tissues taken from more than 1.0 cm adjacent to the carcinoma), and 26 precancerous lesions (leukoplakia) of the larynx. The relationship between the protein expression with the clinical stage and histopathological classification of laryngeal squamous cell carcinoma was analyzed. Results: The positive rates of HPV16, HPV16 E6, and HPV16 E7 protein in precancerous tissues (30.77%, 26.92%, and 26.92%, respectively) were significantly lower than those in laryngeal carcinoma lesions (45.12%, 39.02%, and 42.68%, respectively; P<0.05 or 0.01), but were significantly higher than those in non-carcinoma tissues (23.08%, 5.13%, and 2.56%, respectively; P<0.05 or 0.01). In non-carcinoma tissues, the positive rate of HPV16 protein was significantly higher than that of E6 or E7 (P<0.05 or 0.01), while there was no difference between their positive rates in laryngeal carcinoma or precancerous lesions. We found that human laryngeal carcinoma tissues with different clinical stages and different pathological classifications also had different positive rate of HPV16 protein (P<0.05), but they had a similar positive rate of HPV16 E6 and E7. Conclusion: The expression of HPV16 E6, E7 proteins after the HPV16 infection might be one of the reasons for development of human laryngeal carcinoma. Inhibition of HPV16E7 expression by immunologic strategy may have a potential for treatment of laryngeal carcinoma.
Keywords:laryngeal neoplasms   carcinoma, squamous cell   HPV16 protein   HPV16 E6 protein   HPV16 E7 protein
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《第二军医大学学报》浏览原始摘要信息
点击此处可从《第二军医大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号